REG - Haleon PLC - Director/PDMR Shareholding
02/07/2025 12:30
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250702:nRSB4383Pa&default-theme=true
RNS Number : 4383P Haleon PLC 02 July 2025
Haleon plc: Director/PDMR Shareholding
2 July 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").
On 30 June 2025, Dawn Allen, Chief Financial Officer, received the vesting of
awards of Haleon Ordinary Shares under the Haleon Share Value Plan and
Performance Share Plan.
The awards under the Share Value Plan and Performance Share Plan were granted
as part of her remuneration arrangements upon joining Haleon, to compensate
for forfeited incentives from her previous employment.
The award under the Performance Share Plan includes dividends accrued and was
conditional on continued employment and based on the satisfaction of the
original performance conditions over the performance period ending 31 March
2025 in respect of forfeited incentives. This award (after tax on the gross
award) must be retained until the shareholding requirement is met, and in any
event for Executive Directors two years after receipt.
The awards are subject to malus and clawback provisions.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dawn Allen
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the vesting of the Haleon plc
Share Value Plan (Buyout award).
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 41,484
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 30 June 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from Haleon plc Share Value
Plan (Buyout award) vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.75638 19,565.960864
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 30 June 2025
f) Place of the transaction London Stock Exchange (XLON)
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the vesting of the Haleon plc
Performance Share Plan (Buyout).
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 136,528.6549
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 30 June 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from Haleon plc Performance
Share Plan (Buyout) vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.75638 64,329.291
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 30 June 2025
f) Place of the transaction London Stock Exchange (XLON)
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com (http://www.haleon.com/)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBBGDRRGGDGUDRecent news on HALEON
See all newsREG - Haleon PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC - Historic Proforma Category Financial Performance
AnnouncementREG - Haleon PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC - Total Voting Rights and Capital
AnnouncementREG - Haleon PLC - Completed acquisition of remaining 12% in China JV
Announcement